Brief: Y-Mabs Names Michael Rossi As President And Chief Executive Officer And Director
18/10/2023 22:33
Oct 18 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS NAMES MICHAEL ROSSI AS PRESIDENT AND CHIEF
EXECUTIVE
OFFICER AND DIRECTOR
* Y-MABS THERAPEUTICS -BOARD HAS APPOINTED MICHAEL ROSSI AS
PRESIDENT, CEO WITH AN EXPECTED START DATE OF NOVEMBER 6, 2023
Source text for Eikon: ID:nGNX2Kfy33
Further company coverage: YMAB.O
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary